Moleculin Biotech, Inc.
NASDAQMBRX short interest surges 108% in one week to 1.2% of float, driven by 43% single-day jump on May 14. Cost to borrow stands at 68.5%, with utilization at 74%.
Snapshot as of 28 Jun 2026
Moleculin Biotech enters its May 19 earnings report with the borrow market under real pressure — and a short score near the top of the universe. The most striking development this week is how rapidly shorts have built.…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MBRX — free to start on ORTEX.
Sign up for free →Open MBRX on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live MBRX data →